Thicker, Longer, Darker Eyelashes with FDA-Approved LATISSE Now In Stock at The Skin Center Medical Spa

FDA-Approved LATISSE™ is clinically proven to grow longer, darker and thicker eyelashes in as little as eight weeks and is available at The Skin Center Medical Spa with locations in Pittsburgh, PA and Columbus, Ohio.

Pittsburgh, PA (PRWEB) June 1, 2009 -- The FDA-approved prescription-based cosmetic product, LATISSE™, designed to lengthen, strengthen and darken eyelashes has become one of the most requested products for women and men of all ages at The Skin Center Medical Spa (http://www.theskincentermd.com) with locations in Pittsburgh, PA and Columbus, Ohio.

The Skin Center Medical Spa has seen a surge in requests for LATISSE™ (http://www.theskincentermd.com/treatment/latisse.htm) lash enhancement from men and women in their 20s through 80s for its ability to grow thicker lashes and longer lashes that are substantially darker. LATISSE™ is a once-daily prescription treatment applied to the base of the upper eyelashes with a sterile, single-use-per-eye disposable applicator. LATISSE™ users can expect to experience longer, fuller and darker eyelashes in as little as eight weeks, with full results in 16 weeks.

"More and more of our clients have been requesting LATISSE™ for its ability to rejuvenate short and brittle eyelashes," said Dr. Dominic Brandy (http://www.theskincentermd.com/staff.htm), board-certified cosmetic surgeon and founding medical director of The Skin Center Medical Spa. "Long, dark, thick eyelashes become the focal point of the face and can help draw attention away from less desirable features. No matter what the person's age, everyone seems they want more beautiful lashes and LATISSE™ is the first product that is clinically proven to deliver those results."

The Skin Center Medical Spa has incorporated LATISSE™ into its exclusive EyeQ™ (http://www.theskincentermd.com/treatment/eyeQ.htm) treatment which is a nonsurgical treatment designed to refresh and rejuvenate tired, older eyes by eliminating wrinkles, the appearance of under eye circles and fat pads in just one quick office visit. EyeQ™ incorporates the use of BOTOX® Cosmetic, injectable wrinkle fillers and topical treatments such as LATISSE™ to create a customized rejuvenation program based the individual needs of each client.

LATISSE™, developed by Allergan, the makers of BOTOX® Cosmetic (http://www.theskincentermd.com/treatment/botox_wrinkle.htm), is the first and only science-based treatment approved by the FDA to enhance eyelash prominence as measured by increases in length, thickness and darkness of eyelashes. To maintain the effect, continued treatment with LATISSE™ is required. If use of LATISSE™ is discontinued, eyelashes will gradually return to where they were prior to treatment over a period of weeks to months (average eyelash hair cycle).

LATISSE™ is available in the United States through a physician's office only and is subject to all U.S. guidelines applicable to dispensing a prescription product.

The Skin Center Medical Spa, located in Pennsylvania and Ohio, is the region's premier, full-service medical spa offering the latest advancements in non-invasive and minimally invasive skin rejuvenation for the treatment of aging skin, hyper-pigmentation, rosacea, unwanted hair, varicose and spider veins, active acne and acne scarring. The Skin Center medical Spa was founded in 1981 in Pittsburgh, PA, by Dominic Brandy, MD, board- certified cosmetic surgeon. For more information about LATISSE™, contact The Skin Center Medical Spa at 1-800-429-1151.

###


Contact Information
NICOLE CONAWAY
The Skin Center Medical Spa
http://www.theskincentermd.com
412-414-1404

Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy